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2,3,7,8-Tetrachlorodibenzo-p-Dioxin Impairs Differentiation
of Normal Human Epidermal Keratinocytes in a Skin
Equivalent Model
To the Editor:
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is an environ-
mental pollutant that is taken up via the food chain and
accumulates in fat tissue. In humans, intoxication with
TCDD causes chloracne, a severe skin disease resulting in
disfiguring scarring (Geusau et al, 1999, 2001). In the past,
various experimental approaches have been adapted to
study the effect of TCDD on keratinocytes (KC) and skin.
In utero exposure of murine fetuses led to an accelerated
terminal differentiation in fetal mouse skin (Loertscher et al,
2002). Treatment of non-transformed human KC cultures
with TCDD resulted in enhanced differentiation, determined
by an increase of involucrin expression and modulation of
expression of a number of growth-regulatory proteins
(Gaido and Maness, 1994). One study on the effects of
TCDD was performed with a spontaneously immortalized
human KC cell line in a three-dimensional (3D) skin equiv-
alent (SE) model, where TCDD caused acceleration of
differentiation as determined by morphological characteri-
zation and by immunohistochemistry for several differenti-
ation-specific protein markers; neither an influence on
proliferation nor an induction of apoptosis was observed
(Loertscher et al, 2001).
In this study, we investigated the effect of TCDD on nor-
mal human epidermal KC grown in a 3D model under dif-
ferentiating conditions (Stark et al, 1999; Rendl et al, 2002).
After exposure of SE to TCDD at concentrations of 108 and
107 M for 1 wk, we quantified alterations of the KC
differentiation process by western blot analysis with anti-
bodies against selected differentiation markers.
In vitro reconstructed SE were generated according to
the protocol of Stark and colleagues with modifications de-
scribed previously (Stark et al, 1999; Rendl et al, 2002).
Starting on the day of lifting the culture to the air interface,
culture medium for SE was supplemented with either TCDD
(AccuStandard Inc., New Haven, Connecticut) (107 and
108 M) or vehicle every 2 d and culture was continued for
up to 7 d. After 3 and 7 d of culture samples were taken
by punch biopsy for hematoxylin & eosin staining and
immunohistochemistry, performed as described previously.
SE were also lyzed in a buffer containing 6 M urea 62.5 mM
Tris/HCl, pH 6.8, 2% SDS, and 10% glycerol and subjected
to western blot analysis as described previously (Rendl
et al, 2002). The following antibodies were used at the in-
dicated concentrations: goat polyclonal anti-CYP1A1
(Gentest Corporation, Woburn, Massachusetts) 1:500,
mouse monoclonal anti-involucrin (NeoMarkers, Fremont,
California) 1:1000, mouse monoclonal anti-filaggrin (Bio-
medical Technologies, Stoughton, Massachusetts) 1:500,
rabbit polyclonal anti-Id-1 (Santa Cruz Biotechnology, Hei-
delberg, Germany) 1:1000, mouse monoclonal anti-p63
(Oncogene Research Products, Boston, Massachusetts)
1:300, mouse monoclonal anti-p16 (NeoMarkers) 1:250,
mouse monoclonal anti-K1/10/11 (Cymbus Biotechnology,
Hampshire, UK) 1:1000, and a rabbit polyclonal anti-
body that we had raised against recombinant human ca-
spase-14 (Alibardi et al, in press).
The most prominent effect of TCDD was an increase of
thickness of the stratum corneum with parakeratosis and a
reduction of viable cell layers after 7 d of treatment, com-
pared with vehicle-treated samples (Fig 1). A complete loss
of the granular layer was visible both on days 3 and 7 of
incubation with TCDD.
For quantitative comparison of SE treated and untreated
with TCDD, the abundance of selected marker proteins was
determined by western blotting. Expression of cytochrome
P450 1A1 (CYP1A1), a dioxin-responsive gene (Xu et al,
2000), was strongly induced in a concentration-dependent
manner (Fig 2), indicating the validity of the model used.
TCDD decreased expression of p63 and Id-1, transcription
factors that are downregulated during terminal KC differen-
tiation (Langlands et al, 2000; Koster and Roop, 2004), at a
concentration of 108 M and virtually abrogated their ex-
pression at 107 M. In line with previous reports on over-
expression of Id-1 in KC (Nickoloff et al, 2000), modulation
of the amount of Id-1 was accompanied by an inverse reg-
ulation of p16 that was concentration-dependently upreg-
ulated by TCDD (Fig 2).
Expression of markers of KC differentiation was hetero-
genous: whereas the abundance of involucrin was increased
by TCDD, the levels of keratins 1 and 10 were decreased
after 7 d of TCDD treatment (Fig 2). Caspase-14, a protease
implicated in terminal differentiation (Eckhart et al, 2000), was
downregulated by TCDD in a concentration-dependent man-
ner. Additionally, processing of pro-caspase-14 to the mature
enzyme subunits was readily detectable in control SE but
was not observed after TCDD treatment. Western blot anal-
ysis of profilaggrin/filaggrin revealed an increase of the abun-
dance of profilaggrin under TCDD exposure. But processing
of profilaggrin into mature filaggrin, one of the final steps of
KC differentiation, was completely blocked by TCDD.
Abbreviations: KC, keratinocytes; SE, skin equivalent; TCDD,
2,3,7,8-tetrachlorodibenzo-p-dioxin
Copyright r 2004 by The Society for Investigative Dermatology, Inc.
275
The results obtained with the SE model support some of
the conclusions drawn from studies in other experimental
systems, but are in contrast to others. An increased ex-
pression of involucrin and profilaggrin has also been re-
ported for monolayer cultures of NHEK (Ray and Swanson,
2003). In contrast to our results, however, Ray and cowork-
ers observed a decrease in the expression level of p16. In
our experiments, TCDD reduced the expression of the dif-
ferentiation markers keratins 1 and 10. This is in accordance
with Rea and coworkers, who reported that TCDD exposure
of normal and immortalized human KC in monolayer culture
led to a reduction of keratins 1 and 10 mRNA (Rea et al,
1998). By contrast, topical application of TCDD in adult
hairless mice resulted in hyperkeratinization and induction
of mouse K1 mRNA expression of the dermal cyst epithe-
lium whereas inter-follicular epidermis was not affected
(Panteleyev et al, 1997). In utero exposure of mouse fetuses
to TCDD resulted in an accelerated filaggrin expression as
judged immunohistochemically, whereas keratins were not
affected (Loertscher et al, 2002).
Hyperkeratosis in the SE indicates that TCDD acceler-
ates differentiation. This effect is represented in the clinical
condition of chloracne in humans, a skin pathology char-
acterized by hyperkeratosis of the sebaceous gland duct,
followed by plugging of the follicular orifice and formation of
cysts filled with keratinous material (Suskind, 1985; Tindall,
1985). But regular completion of the differentiation program
of human KC is prevented, indicated by parakeratosis and
loss of the granular layer. Our data reveal novel effects of
TCDD on late steps of terminal KC differentiation, which
may contribute to the observed morphogical differences
between SE treated and untreated with TCDD. The expres-
sion of caspase-14 was strongly reduced and activation of
the proenzyme by processing into the subunits did not oc-
cur at detectable levels. Even more strikingly, the matura-
tion of profilaggrin into filaggrin monomers was blocked,
which probably correlates with the absence of a granular
layer.
Although the model system used in this study appears to
replicate the in vivo differentiation process of KC more
closely than previously reported models, there are still lim-
itations in its predictive value. TCDD may have additional
effects in vivo that cannot be seen in an SE model, since
several resident and migratory skin cells as well as skin
appendages are not present in this model. Further studies
are necessary to determine if and how the described TCDD
effects at the molecular level contribute to the clinical
effects of TCDD on skin.
Figure 1
Histology of SE treated with TCDD. SE were treated with 107 M TCDD (b, d) or vehicle control (a, c) for 3 (a, b) or 7 d (c, d) and subsequently
subjected to H&E staining. TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; SE, skin equivalent; H&E, hematoxylin & eosin.
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Figure 2
Western blot analysis of differentiation markers in TCDD-treated
SE. SE exposed to 0, 108, and 107 M TCDD for 1 wk were analyzed
by western blotting for Cyp1A1, p63, Id-1, p16, involucrin (inv), K1/10,
caspase-14 (casp-14), filaggrin (fil), and profilaggrin (profil). TCDD,
2,3,7,8-tetrachlorodibenzo-p-dioxin; SE, skin equivalent.
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